Hi Pei,
That's awesome creation... I have few concerns and questions after the parsing clinical note thru' ctakes-temporal (below is the part of result). Could you please help me to resolve my doubts- In below screenshot [image: Inline image 1] 1. "androgen deprivation" is therapy but not classified as Procedure, 2. Active Surveillance (sometimes mentioned as watchful waiting), means patient is under observation, that may not be classified "drug" for "Active". 3. "External Beam Radiation" should also covered under procedure whereas just "Radiation" covers under procedure. Lastly,I need to find if a particulate treatment is happened or not. Could you please suggest the way to determine if the treatment is done for the patient or it is just mentioned/discussed. ClinicalNote is attached for your reference. On Mon, Jun 22, 2015 at 8:05 PM, Finan, Sean < [email protected]> wrote: > Very cool. It allows quick reproducible testing. For example: > > <cas:Sofa xmi:id="1" sofaNum="1" sofaID="_InitialView" mimeType="text" > sofaString="The patient has GBM and that sucks."/> > > <textsem:DiseaseDisorderMention xmi:id="193" sofa="1" begin="16" end="19" > id="0" ontologyConceptArr="145 125 135 155 175 165" typeID="2" > discoveryTechnique="1" confidence="0.0" polarity="0" uncertainty="0" > conditional="false" generic="false" historyOf="0"/> > > <refsem:UmlsConcept xmi:id="165" codingScheme="SNOMEDCT" code="189917003" > score="0.0" disambiguated="false" cui="C0017636" tui="T191" > preferredText="Glioblastoma"/> > <refsem:UmlsConcept xmi:id="175" codingScheme="SNOMEDCT" code="269506004" > score="0.0" disambiguated="false" cui="C0017636" tui="T191" > preferredText="Glioblastoma"/> > <refsem:UmlsConcept xmi:id="155" codingScheme="SNOMEDCT" code="63634009" > score="0.0" disambiguated="false" cui="C0017636" tui="T191" > preferredText="Glioblastoma"/> > <refsem:UmlsConcept xmi:id="135" codingScheme="SNOMEDCT" code="393563007" > score="0.0" disambiguated="false" cui="C1621958" tui="T191" > preferredText="Glioblastoma Multiforme"/> > <refsem:UmlsConcept xmi:id="125" codingScheme="SNOMEDCT" code="63634009" > score="0.0" disambiguated="false" cui="C1621958" tui="T191" > preferredText="Glioblastoma Multiforme"/> > <refsem:UmlsConcept xmi:id="145" codingScheme="SNOMEDCT" code="189917003" > score="0.0" disambiguated="false" cui="C1621958" tui="T191" > preferredText="Glioblastoma Multiforme"/> > > This is extremely useful! > > -----Original Message----- > From: Pei Chen [mailto:[email protected]] > Sent: Friday, June 19, 2015 11:33 AM > To: [email protected]; [email protected] > Subject: Apache cTAKES hosted demos and examples > > There seems to be a significant interest in having a hosted demo and > examples, so I started this index page along with initial code examples: > > Index page: > > https://urldefense.proofpoint.com/v2/url?u=http-3A__healthnlp.github.io_examples_&d=BQIBaQ&c=qS4goWBT7poplM69zy_3xhKwEW14JZMSdioCoppxeFU&r=fs67GvlGZstTpyIisCYNYmQCP6r0bcpKGd4f7d4gTao&m=Qiv3CPnn_kSAs-guC8v9Zd6RuvSU5TftExH8bS5kN5A&s=QIjhvps1xpM3shTSmpKSWNdpp51hhrdvZTEFxtxjLE0&e= > > Live demo: > > https://urldefense.proofpoint.com/v2/url?u=http-3A__52.24.118.198-3A8080_index.jsp&d=BQIBaQ&c=qS4goWBT7poplM69zy_3xhKwEW14JZMSdioCoppxeFU&r=fs67GvlGZstTpyIisCYNYmQCP6r0bcpKGd4f7d4gTao&m=Qiv3CPnn_kSAs-guC8v9Zd6RuvSU5TftExH8bS5kN5A&s=WccVDuNaCd-0oHrPBxznasYuMRxkZP_0HHmFlhOR0dY&e= > > --Pei > -- ** Please include your practice ID in your correspondence.* Sincerely, Sangram Patil Team Lead-Core Dev Cell: +91 992 293 9497 figmd.com <http://www.figmd.com/> CONFIDENTIALITY NOTICE <http://www.figmd.com/terms/>
Greater than 30 minutes of face to face discussion time were spent discussing the prostate gland, prostate diseases and prostate cancer. The discussion was tailored to the patient's age, overall health and his cancer stage and gleason score. He was given literature. We discussed open radical prostatectomy, daVinci prostatectomy, external beam radiation, brachytherapy, cryotherapy, androgen deprivation, Active Surveillance and HIFU. The patient was informed of the potential efficacy and side effects of each. Second opinions (oncologist, radiation oncologist and pathology) were offered to the patient. The size of his prostate gland was discussed as it impacts treatment. While the choice is ultimately up to the patient and his family, he has elected DaVinci robotic prostatectomy. He understands that the procedure does not ensure cure, that he may require additional therapy and that there is a remote possibility of blood transfusion. He understands that temporary incontinence is likely and that long term incontinence is a possibility. He understands the risks of post-operative impotence. He understands that nerve-sparing will only be attempted if deemed oncologically appropriate, and does not ensure potency. He understands that while he should be able to achieve orgasm, he will be an ejaculatory. He can anticipate 1 to 2 nights in the hospital, a catheter for 7 to 14 days, no driving for 2 weeks and at least 4 weeks of disability.
